PACAP38/PAC1 signaling induces bone marrow-derived cells homing to ischemic brain

Stem Cells. 2015 Apr;33(4):1153-72. doi: 10.1002/stem.1915.

Abstract

Understanding stem cell homing, which is governed by environmental signals from the surrounding niche, is important for developing effective stem cell-based repair strategies. The molecular mechanism by which the brain under ischemic stress recruits bone marrow-derived cells (BMDCs) to the vascular niche remains poorly characterized. Here we report that hypoxia-inducible factor-1α (HIF-1α) activation upregulates pituitary adenylate cyclase-activating peptide 38 (PACAP38), which in turn activates PACAP type 1 receptor (PAC1) under hypoxia in vitro and cerebral ischemia in vivo. BMDCs homing to endothelial cells in the ischemic brain are mediated by HIF-1α activation of the PACAP38-PAC1 signaling cascade followed by upregulation of cellular prion protein and α6-integrin to enhance the ability of BMDCs to bind laminin in the vascular niche. Exogenous PACAP38 confers a similar effect in facilitating BMDCs homing into the ischemic brain, resulting in reduction of ischemic brain injury. These findings suggest a novel HIF-1α-activated PACAP38-PAC1 signaling process in initiating BMDCs homing into the ischemic brain for reducing brain injury and enhancing functional recovery after ischemic stroke.

Keywords: Bone marrow-derived cells; Hypoxia-inducible factor-1α; PACAP38/PAC1 signaling; Stroke; Vascular niche.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / metabolism*
  • Brain / metabolism*
  • Brain / pathology
  • Brain Ischemia / metabolism*
  • Cells, Cultured
  • HEK293 Cells
  • Humans
  • Male
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Pituitary Adenylate Cyclase-Activating Polypeptide / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / biosynthesis*
  • Signal Transduction / physiology

Substances

  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I